Telix to Participate in UBS Global Biopharma Conference

MELBOURNE, Australia and INDIANAPOLIS, Nov. 11, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") will participate in the upcoming UBS Global Biopharma Conference in London (UK). Dr. Christian Behrenbruch, Managing Director and Group CEO, and Mr. Richard...

Published on The Global News Feed

11 Nov 2026, 07:44 UTC